The
global erectile dysfunction drugs market was worth $4.3 billion in
2012. It is expected to decline at an aggregate rate of 4.5% between
2013 and 2019, which means the market will be valued at $3.4 billion
in 2019.
Browse
the full report with complete TOC at Erectile Dysfunction Drugs
Market
http://www.transparencymarketresearch.com/erectile-dysfunction-drugs.html
All
facts and figures have be provided through a research report titled
“Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn,
Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) - Global Industry
Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”,
published by Transparency Market Research.
The
report showed that Viagra (sildenafil citrate) by Pfizer held 45% of
the global erectile dysfunction drugs market in 2012. Its majority
hold over the market is predicted to decline after patent exclusivity
rights expire in 2013 in Europe and other countries. Cialis
(tadalafil) held the second-largest market share with $1.9 billion in
2012. Its patent exclusivity will reportedly expire in 2017,
supplementing the decline of the erectile dysfunction drugs market by
2019. The same is to be expected from Levitra/Staxyn (Vardenafil) by
Bayer, whose patent exclusivity is set to expire in 2018. The report
explains that once the patents expire, the market will be flooded
with competitive generic drugs with similar chemical compositions,
reducing the revenue generated by the major players in the market.
Request
for customization of this report
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1550
Factors
that might improve the growth of the erectile dysfunction drugs
market are the approval of the new promising drugs Zydena (udenafil)
and Stendra/Spedra (avanafil) in mid 2014.
The
report categorized the global erectile dysfunction market according
to the product brands or pipeline analysis. By products, the report
investigates Viagra, Cialis, Levitra/Staxyn, MUSE, Zydena, Mvix, and
Helleva. By pipeline analysis, the report identifies Vitaros, Uprima,
Gene therapy, Melanocortin Activators, and Topiglan.
Browse
all Press Releases:
http://www.transparencymarketresearch.com/press-releases.htm
By
geography, the research report identifies the regions of North
America, Europe, Asia-Pacific, and Rest of the World. The North
American region dominated the global erectile dysfunction drug market
in revenue created. It is expected to maintain its dominance
throughout the forecast period.
The
key players explained in the report are Pfizer, GlaxoSmithKline,
Bayer, Dong-A Pharmaceutical Corporation Limited, Eli Lilly And
Company, Cristalia Produtos Quimicos Farmaceuticos Ltda., Vivus
Incorporated, S.K. Chemicals Corporation Limited, Meda
Pharmaceuticals, and Apricus Biosciences, Incorporated.
Browse
all Article :
http://www.transparencymarketresearch.com/articles.htm
Erectile
dysfunction is a male inability to generate and/or maintain penile
erection, for the sake of a fully successful sexual intercourse. It
primarily affects men above the age of 40. Typical causes of erectile
dysfunction are diabetes and hypertension, along with a host of
common habits attributed to a sedentary lifestyle, obesity, excessive
consumption of alcohol, smoking, use of recreational drugs, and use
of anti-depressants.
Browse
all Pharmaceutical Market Research Reports @
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About
Us
Transparency
Market Research is a global market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We are
privileged with highly experienced team of Analysts, Researchers, and
Consultants, who use proprietary data sources and various tools and
techniques to gather, and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.
Contact:
Sheela
AK
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA/Canada
Toll Free: 866-552-3453
Blog:
http://www.tmrblog.com/
No comments:
Post a Comment